Watch XTNT. Know when insiders buy.
One email the day a filing lands. Free.
XTNT
Xtant Medical Holdings, Inc.
0.34
−0.01 −2.86%
USD · close Oct 2
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
0
FLAG · shorts 0
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $47.7MP/E —DIV YIELD —FCF YIELD -1.46%REV TTM $109.5M −14.3%NET INCOME −$11.1MNET CASH $2.6M52W 0.31 – 0.92SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $23M | −35.0% | 57.9% | −$9.2M | −$9.4M | −365.2% | -0.07 | −$7.3M | $247K | −$7.6M | Aug 11 |
| Q1 2026 · Mar 31 | $20.9M | −36.5% | 57.3% | −$2.9M | −$3.1M | −5425.9% | -0.02 | −$2.1M | $194K | −$2.3M | Aug 11 |
| Q4 2025 · Dec 31derived | $32.4M | +2.7% | 54.9% | −$944K | $57K | — | 0.00 | $5.4M | $395K | $5M | Mar 31 |
| Q3 2025 · Sep 30 | $33.3M | +19.0% | 66.1% | $2.5M | $1.3M | — | 0.01 | $4.6M | $430K | $4.2M | Nov 10 |
| Q2 2025 · Jun 30 | $35.4M | +18.3% | 68.6% | $4.6M | $3.5M | — | 0.02 | $1.3M | $366K | $910K | Aug 11 |
| Q1 2025 · Mar 31 | $32.9M | +18.0% | 61.5% | $1.1M | $58K | — | 0.00 | $1.3M | $1.2M | $87K | Aug 11 |
| Q4 2024 · Dec 31derived | $31.5M | +12.1% | 50.8% | −$1.9M | −$3.2M | — | -0.02 | $665K | $672K | −$7K | Mar 31 |
| Q3 2024 · Sep 30 | $27.9M | +11.7% | 58.4% | −$3.8M | −$5M | −154.4% | -0.04 | −$1.7M | $2.1M | −$3.8M | Nov 10 |
| Q2 2024 · Jun 30 | $29.9M | — | 62.1% | −$2.9M | −$3.9M | — | -0.03 | −$5.1M | $564K | −$5.7M | Nov 10 |
| Q1 2024 · Mar 31 | $27.9M | — | 62.1% | −$3.5M | −$4.4M | — | -0.03 | −$5.8M | $773K | −$6.5M | Nov 10 |
| Q4 2023 · Dec 31derived | $28.1M | — | 61.0% | −$3.8M | −$4.3M | — | -0.03 | −$915K | $363K | −$1.3M | Mar 6 |
| Q3 2023 · Sep 30 | $25M | — | 61.3% | −$3.4M | $9.2M | — | 0.07 | −$3.8M | $223K | −$4.1M | Nov 12 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $133.9M | 62.9% | $7.3M | $5M | 3.7% | 0.03 | $12.5M | $2.4M | $10.2M | — | — |
| FY2024 · to Dec 31 | $117.3M | 58.2% | −$12.1M | −$16.4M | -14.0% | -0.12 | −$11.9M | $4.1M | −$16M | — | — |
| FY2023 · to Dec 31 | $91.3M | 60.8% | −$10.2M | $660K | 0.7% | 0.01 | −$9.5M | $1.5M | −$11M | — | — |
| FY2022 · to Dec 31 | $58M | 55.4% | −$6.8M | −$8.5M | -14.6% | -0.09 | −$5.3M | $1.8M | −$7.1M | — | — |
| FY2021 · to Dec 31 | $55.3M | 58.8% | −$3.9M | −$4.8M | -8.8% | -0.06 | $439K | $2.1M | −$1.7M | — | — |
| FY2020 · to Dec 31 | $53.3M | 64.5% | −$751K | −$7M | -13.2% | -0.25 | −$731K | $1.5M | −$2.3M | — | — |
Every number comes from Xtant Medical Holdings, Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.